Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 7:31 AM ET

Date/Time Source News Release
04/29/2025 04:05 PM EDT Business Wire Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates
04/22/2025 04:16 PM EDT PR Newswire Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
04/15/2025 06:30 AM EDT Business Wire Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
04/11/2025 10:50 PM EDT Business Wire SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE
03/17/2025 02:10 PM EDT Business Wire SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE
03/13/2025 06:21 PM EDT GlobeNewswire Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf
03/12/2025 08:26 AM EDT GlobeNewswire Long-Term Shareholder Notice: Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf
03/08/2025 01:56 PM EST Newsfile Grabar Law Office Investigates Claims on Behalf of Shareholders of Sage Therapeutics, Inc. (SAGE)
03/04/2025 04:15 PM EST Business Wire Sage Therapeutics Announces R&D Leadership Transition
02/11/2025 04:05 PM EST Business Wire Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates
Page

Additional News

As of April 30, 2025 • 7:31 AM ET

Date/Time Source News Release
04/29/2025 10:34 PM EDT SeekingAlpha Sage Therapeutics outlines Q1 2025 growth in ZURZUVAE prescriptions and pipeline progress
04/29/2025 10:33 PM EDT SeekingAlpha Sage Therapeutics, Inc. (SAGE) Q1 2025 Earnings Call Transcript
04/29/2025 05:15 PM EDT Zacks Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates
04/29/2025 04:31 PM EDT SeekingAlpha Sage Therapeutics GAAP EPS of -$1.01 beats by $0.02, revenue of $14.06M beats by $0.05M
04/29/2025 10:00 AM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Shareholders to Inquire about Securities Investigation
04/29/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
04/29/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, April 29th, 2025
04/29/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sage Therapeutics Inc.
04/28/2025 06:48 PM EDT KlickAnalytics SAGE - Historical Price Movements Surrounding Earnings
04/28/2025 06:43 PM EDT KlickAnalytics SAGE - Historical Earnings Price Analysis
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.